AVANT GARDE (Completed)

A randomized, double-blind, parallel-group, placebocontrolled, multinational clinical trial to evaluate the efficacy of Aliskiren and valsartan versus placebo in lowering levels on NT-proBNP in stabilized patients post acute coronary syndromes